Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 9, 2009, Pages 3365-3371

  Barahona, María José ^a,b,d   Sucunza, Nuria ^a,b   Resmini, Eugenia ^a,b   Fernández Real, José Manuel ^c   Ricart, Wifredo ^c   Moreno Navarrete, José María ^c   Puig, Teresa ^b   Farrerons, Jordi ^b   Webb, Susan M ^a,b  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APOLIPOPROTEIN B; INSULIN; INTERLEUKIN 6; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CUSHING SYNDROME; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION;

EID: 69949093791     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0766     Document Type: Article

References (31)

1. Burt MG, Gibney J, Ho KK 2006 Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a study of body composition and energy metabolism. Clin Endocrinol (Oxf) 64:436-443
2. Shaker JL, Lukert BP 2005 Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am 34:341-356, viii-ix
3. Ueland T, Kristo C, Godang K, Aukrust P, Bollerslev J 2003 Interleukin- 1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study. J Clin Endocrinol Metab 88:1492-1496 (Pubitemid 36623359)
4. Pirlich M, Biering H, Gerl H, Ventz M, Schmidt B, Ertl S, Lochs H 2002 Loss of body cell mass in Cushing's syndrome: effect of treatment. J Clin Endocrinol Metab 87:1078-1084 (Pubitemid 36121069)
5. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G 1999 Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672 (Pubitemid 30641990)
6. Ronti T, Lupattelli G, Mannarino E 2006 The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64:355-365
7. Trujillo ME, Scherer PE 2006 Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27:762-778 (Pubitemid 44936059)
8. Fernández-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C 1998 Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47:1757-1762 (Pubitemid 28476250)
9. Santaniemi M, Kesäniemi YA, Ukkola O 2006 Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 155:745-1150
10. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y; Osaka CAD Study Group Coronary artery disease 2003 Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89 (Pubitemid 36091630)
11. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B 2007 Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 92:571-576 (Pubitemid 46255297)
12. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M 2003 Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108:2317-2322 (Pubitemid 37413536)
13. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB 2004 Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599-2610 (Pubitemid 39628581)
14. Webb SM, Rigla M, Wägner A, Oliver B, Bartumeus F 1999 Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab 84:3696-3700 (Pubitemid 30645227)
15. National Cholesterol Education Program (NCEP) Expert Panel 2002 Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), final report. Circulation 106:3143-3421
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith Jr SC, Spertus JA, Costa F 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752
17. Krsek M, Silha JV, Jezková J, Hána V, Marek J, Weiss V, Stepán JJ, Murphy LJ 2004 Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome. Clin Endocrinol (Oxf) 60:350-357 (Pubitemid 38297126)
18. Fallo F, Scarda A, Sonino N, Paoletta A, Boscaro M, Pagano C, Federspil G, Vettor R 2004 Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. Eur J Endocrinol 150:339-344 (Pubitemid 38443784)
19. Kristo C, Godang K, Ueland T, Lien E, Aukrust P, Froland SS, Bollerslev J 2002 Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome. Eur J Endocrinol 146:389-395 (Pubitemid 34257650)
20. Abad V, Chrousos GP, Reynolds JC, Nieman LK, Hill SC, Weinstein RS, Leong GM 2001 Glucocorticoid excess during adolescence leads to a major persistent deficit in bone mass and an increase in central body fat. J Bone Miner Res 16:1879-1885 (Pubitemid 32911495)
21. Leong GM, Abad V, Charmandari E, Reynolds JC, Hill S, Chrousos GP, Nieman LK 2007 The effects of child-and adolescent-onset endogenous Cushing syndrome on bone mass, body composition and growth: a 7-year prospective study into young adulthood. J Bone Miner Res 22:110-118 (Pubitemid 46032603)
22. Pivonello R, Faggiano A, Lombardi G, Colao A 2005 The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin North Am 34:327-339, viii (Pubitemid 40602724)
23. Stewart PM 2003 Tissue-specific Cushing's syndrome, 11β- hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur J Endocrinol 149:163-168
24. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM 2004 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866 (Pubitemid 39366049)
25. Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213
26. Chrousos GP 2000 The role of stress and the hypothalamic-pituitary- adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrin and target tissue-related causes. Int J Obes 24(Suppl 2): S50-S55
27. Rosmond R, Björntorp P 2000 Occupational status, cortisol secretory pattern and visceral obesity in middle-aged men. Obes Res 8:445-450
28. Kola B, Christ-Crain M, Lolli F, Arnaldi G, Giacchetti G, Boscaro M, Grossman AB, Korbonits M 2008 Changes in AMP-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. J Clin Endocrinol Metab 93:4969-4973
29. Etxabe J, Vazquez JA 1994 Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479-484 (Pubitemid 24194645)
30. Manco M, Fernandez-Real JM, Equitani F, Vendrell J, Valera Mora ME, Nanni G, Tondolo V, Calvani M, Ricart W, Castagneto M, Mingrone G 2007 Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 92:483-490 (Pubitemid 46255284)
31. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D 2002 Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804-809 (Pubitemid 34174919)